Clinical Cancer Research CR Surrogrates AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Brooks, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Brooks, M. N.
Clinical Cancer Research Vol. 10, 3504-3508, May 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Expression Pattern of the Novel Gene EG-1 in Cancer

Liping Zhang1, Raymond Scott Maul1, JianYu Rao2, Sophia Apple2, David Seligson2, Maryam Sartippour1, Rosalio Rubio1 and Mai N. Brooks1

1 Department of Surgery, Division of Oncology, and 2 Department of Pathology, University of California at Los Angeles, Los Angeles, California

Purpose: We recently discovered a novel gene responsive to tumor-conditioned media: endothelial-derived gene 1 (EG-1). Its transcript has been shown to be present in epithelial cells, as well as in endothelial cells. In this study, we examined the levels of EG-1 protein expression in breast, colon, prostate, and lung cancers, which constitute the four most common solid malignancies in the United States.

Experimental Design: Polyclonal antibodies were generated that recognize the EG-1 peptide. These antibodies were used in immunoblot analysis, as well as immunohistochemistry of multiple human clinical specimens of cancer.

Results: In immunoblots of whole cell lysates, EG-1 antibodies revealed the presence of a 22-kDa peptide. Immunohistochemistry of breast, colon, and prostate specimens showed higher levels of EG-1 peptides in cancer tissues, in comparison with their benign counterparts. However, EG-1 expression was minimal in both benign and malignant lung tissues.

Conclusions: Here, we demonstrated that the expression of EG-1 is elevated in cancerous in comparison to benign epithelial cells, as seen in immunohistochemistry of human pathological specimens. These observations collectively support the hypothesis that the novel gene EG-1 is associated with the malignant phenotype of the common epithelial-derived cancers of the breast, colon, and prostate.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. S. Beyer, R. L. Beauchamp, M.-F. Lee, J. F. Gusella, A. M. Naar, and V. Ramesh
Mediator Subunit MED28 (Magicin) Is a Repressor of Smooth Muscle Cell Differentiation
J. Biol. Chem., November 2, 2007; 282(44): 32152 - 32157.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Lu, L. Zhang, R. S. Maul, M. R. Sartippour, A. Norris, J. Whitelegge, J. Y. Rao, and M. N. Brooks
The Novel Gene EG-1 Stimulates Cellular Proliferation
Cancer Res., July 15, 2005; 65(14): 6159 - 6166.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.